Collectively, these findings further imply the complications of the TGF-β pathway in the immune evasion of GI cancer and provide a pivotal role for immune cell modulation in the tumor-facilitating efficiencies of the TGF-β signaling pathway in GI cancer. This evidence concerns the gene TGFB1 and neoplasm.